Ryman Healthcare Statistics
Total Valuation
Ryman Healthcare has a market cap or net worth of 2.03 billion. The enterprise value is 3.51 billion.
| Market Cap | 2.03B |
| Enterprise Value | 3.51B |
Important Dates
The next estimated earnings date is Wednesday, November 27, 2024.
| Earnings Date | Nov 27, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +33.18% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 651.47M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 1,227.13 |
| EV / Sales | 8.70 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 14.87 |
Financial Position
The company has a current ratio of 0.14, with a Debt / Equity ratio of 0.58.
| Current Ratio | 0.14 |
| Quick Ratio | 0.12 |
| Debt / Equity | 0.58 |
| Debt / EBITDA | 131.34 |
| Debt / FCF | 6.53 |
| Interest Coverage | -0.12 |
Financial Efficiency
Return on equity (ROE) is 0.11% and return on invested capital (ROIC) is -0.07%.
| Return on Equity (ROE) | 0.11% |
| Return on Assets (ROA) | -0.04% |
| Return on Capital (ROIC) | -0.07% |
| Revenue Per Employee | 53,428 |
| Profits Per Employee | 371 |
| Employee Count | 7,700 |
| Asset Turnover | 0.05 |
| Inventory Turnover | 76.67 |
Taxes
| Income Tax | -90.28M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -18.24% in the last 52 weeks. The beta is 0.82, so Ryman Healthcare's price volatility has been lower than the market average.
| Beta (5Y) | 0.82 |
| 52-Week Price Change | -18.24% |
| 50-Day Moving Average | 14.33 |
| 200-Day Moving Average | 13.42 |
| Relative Strength Index (RSI) | 50.85 |
| Average Volume (20 Days) | 171 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Ryman Healthcare had revenue of 411.39 million and earned 2.86 million in profits. Earnings per share was 0.00.
| Revenue | 411.39M |
| Gross Profit | 21.35M |
| Operating Income | -4.86M |
| Pretax Income | -86.71M |
| Net Income | 2.86M |
| EBITDA | 9.47M |
| EBIT | -4.86M |
| Earnings Per Share (EPS) | 0.00 |
Balance Sheet
The company has 31.20 million in cash and 1.54 billion in debt, giving a net cash position of -1.51 billion.
| Cash & Cash Equivalents | 31.20M |
| Total Debt | 1.54B |
| Net Cash | -1.51B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 2.64B |
| Book Value Per Share | 3.86 |
| Working Capital | -3.07B |
Cash Flow
In the last 12 months, operating cash flow was 393.99 million and capital expenditures -158.21 million, giving a free cash flow of 235.78 million.
| Operating Cash Flow | 393.99M |
| Capital Expenditures | -158.21M |
| Free Cash Flow | 235.78M |
| FCF Per Share | n/a |
Margins
Gross margin is 5.19%, with operating and profit margins of -1.18% and 0.69%.
| Gross Margin | 5.19% |
| Operating Margin | -1.18% |
| Pretax Margin | -21.08% |
| Profit Margin | 0.69% |
| EBITDA Margin | 2.30% |
| EBIT Margin | -1.18% |
| FCF Margin | 57.31% |
Dividends & Yields
Ryman Healthcare does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -33.18% |
| Shareholder Yield | -33.18% |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Ryman Healthcare has an Altman Z-Score of 0.19 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.19 |
| Piotroski F-Score | 6 |